Data / Form D filings / Receptos, Inc.
Receptos, Inc.: Form D filings
Receptos, Inc., a pharmaceuticals company in San Diego, CA, filed 3 Form D notices with the SEC between 2009 and 2012. The latest, on February 17, 2012, reports $10.8 million sold of a $50 million offering to 11 investors.
Find out what Receptos, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10835 ROAD TO THE CURE, SUITE 205, San Diego, CA, 92121
- Phone
- (858) 652-5712
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1463729
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 17, 2012 | New notice | $50,000,011 | $10,806,610 | $39,193,401 | 11 | Feb 3, 2012 | sec.gov |
| Nov 23, 2009 | New notice | $20,024,000 | $11,999,999 | $8,024,001 | 6 | Nov 9, 2009 | sec.gov |
| May 22, 2009 | New notice | $7,673,456 | $7,673,456 | $0 | 14 | May 11, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Amir Nashat | Director | |
| Marcus Boehm | Executive Officer | |
| William Rastetter | Director | |
| Faheem Hasnain | Executive Officer, Director | |
| Ed Torres | Director | |
| Robert Peach | Executive Officer | |
| Doug Cole | Director | |
| James Schmidt | Executive Officer | |
| Chrysa Mineo | Executive Officer | |
| Kristina Burow | Director | |
| Sheila Gujrathi | Executive Officer | |
| Raymond Stevens | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Feb 13, 2012 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Receptos, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.